GlassScriptPhysician profile
Hunter A Simpson
NPI 1578092870
$2,701.64
in general payments reported to CMS, 2019-2025
17 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $354 · 2023: $1,856 · 2024: $333 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Travel and Lodging: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.63 |
| Travel and Lodging | $564.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,048.60 | 2022-2024 | Proclaim, Eterna |
| Abbvie INC. | $552.81 | 2022-2025 | Ubrelvy, Qulipta, Botox |
| Pfizer INC. | $354.85 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $212.92 | 2022-2023 | Belbuca, Xtampza |
| Globus Medical, INC. | $143.42 | 2025 | Senza |
| Idorsia Pharmaceuticals US INC | $114.47 | 2022-2023 | Quviviq |
| Boston Scientific Corporation | $60.56 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.25 | 2023 | Relistor |
| Medtronic, INC. | $29.85 | 2023 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $24.20 | 2023 | Ha Minuteman G3-R |
| Upsher-Smith Laboratories LLC | $21.52 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.00 | 2024 | |
| Spr Therapeutics, INC | $20.52 | 2023 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $19.38 | 2023 | Dysport |
| Pacira Pharmaceuticals Incorporated | $16.76 | 2023 | Zilretta, Iovera |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $15.44 | 2023 | Nalu Neurostimulation System |
| Biohaven Pharmaceutical Holding Company LTD. | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.